Literature DB >> 16678460

Hereditary renal hypouricemia.

Oded Sperling1.   

Abstract

Hereditary renal hypouricemia (HRH) is an inborn error of renal membrane transport specific for uric acid, resulting in increased renal urate clearance associated with hypouricemia. Apparently in most HRH patients, the disorder is caused by loss of function mutations in the gene SLC22A12 coding for human urate transporter 1 (hURAT1), shown to control urate reabsorption in the proximal tubules. The small group of HRH patients with normal SLC22A12 may be affected with mutations in other not yet identified urate transporters. Patients affected with SLC22A12 mutations exhibit attenuated response of urinary urate excretion to pyrazinamide (PZA) and to probenecid (PBD) loading, attributed previously to reflect defective tubular presecretory urate reabsorption. HRH is inherited in an autosomal recessive mode. Most HRH patients are asymptomatic, but some may form renal tract stones and or be predisposed to exercise-induced acute renal failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678460     DOI: 10.1016/j.ymgme.2006.03.015

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  9 in total

1.  Non-urate transporter 1-related renal hypouricemia and acute renal failure in an Israeli-Arab family.

Authors:  Hilla Bahat; Dganit Dinour; Liat Ganon; Leonid Feldman; Eli J Holtzman; Michael Goldman
Journal:  Pediatr Nephrol       Date:  2009-02-03       Impact factor: 3.714

2.  Potential mechanisms for low uric acid in Parkinson disease.

Authors:  Radhika Sampat; Sarah Young; Ami Rosen; Douglas Bernhard; David Millington; Stewart Factor; H A Jinnah
Journal:  J Neural Transm (Vienna)       Date:  2016-01-08       Impact factor: 3.575

3.  Homozygous SLC2A9 mutations cause severe renal hypouricemia.

Authors:  Dganit Dinour; Nicola K Gray; Susan Campbell; Xinhua Shu; Lindsay Sawyer; William Richardson; Gideon Rechavi; Ninette Amariglio; Liat Ganon; Ben-Ami Sela; Hilla Bahat; Michael Goldman; Joshua Weissgarten; Michael R Millar; Alan F Wright; Eliezer J Holtzman
Journal:  J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 10.121

4.  A Case Report of Familial Renal Hypouricemia Confirmed by Genotyping of SLC22A12, and a Literature Review.

Authors:  Hyung Oh Kim; Chun-Gyoo Ihm; Kyung Hwan Jeong; Hyun Joon Kang; Jae-Min Kim; Hyung Suk Lim; Jin Sug Kim; Tae Won Lee
Journal:  Electrolyte Blood Press       Date:  2015-12-30

5.  A novel homozygous GLUT9 mutation cause recurrent exercise-induced acute renal failure and posterior reversible encephalopathy syndrome.

Authors:  Li-jun Mou; Lan-ping Jiang; Ying Hu
Journal:  J Nephrol       Date:  2014-03-19       Impact factor: 3.902

6.  The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study.

Authors:  Yasuko Aida; Yoko Shibata; Daisuke Osaka; Shuichi Abe; Sumito Inoue; Koji Fukuzaki; Yoshikane Tokairin; Akira Igarashi; Keiko Yamauchi; Takako Nemoto; Keiko Nunomiya; Hiroyuki Kishi; Masamichi Sato; Tetsu Watanabe; Tsuneo Konta; Sumio Kawata; Takeo Kato; Isao Kubota
Journal:  Int J Med Sci       Date:  2011-08-05       Impact factor: 3.738

7.  Clinical and functional characterization of URAT1 variants.

Authors:  Velibor Tasic; Ann Marie Hynes; Kenichiro Kitamura; Hae Il Cheong; Vladimir J Lozanovski; Zoran Gucev; Promsuk Jutabha; Naohiko Anzai; John A Sayer
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

8.  Contribution of SLC22A12 on hypouricemia and its clinical significance for screening purposes.

Authors:  Do Hyeon Cha; Heon Yung Gee; Raul Cachau; Jong Mun Choi; Daeui Park; Sun Ha Jee; Seungho Ryu; Kyeong Kyu Kim; Hong-Hee Won; Sophie Limou; Woojae Myung; Cheryl A Winkler; Sung Kweon Cho
Journal:  Sci Rep       Date:  2019-10-07       Impact factor: 4.379

9.  Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog.

Authors:  Danika Bannasch; Noa Safra; Amy Young; Nili Karmi; R S Schaible; G V Ling
Journal:  PLoS Genet       Date:  2008-11-07       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.